Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Top Healthcare and Tech

Nothing is spookier and scarier on Halloween than an uncertain market! That’s exactly what investors have been dealing with lately, and part of what we’ll try to demystify this week. Lots of companies have been moving independent of the...
Omri Wallach | October 30, 2019 |

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...
Knox Henderson | February 1, 2024 |

Vivus Shares Climb 50% Higher on sNDA Approval for Exocrine Pancreatic Insufficiency Drug

Shares of Vivus traded higher after the FDA approved the company's supplemental New Drug Application for an improved formulation of PANCREAZE® (pancrelipase) for use in the treatment of exocrine pancreatic insufficiency due to cystic fibrosis and other conditions. ...
Streetwise Reports | February 6, 2020 |

BP, Exxon, Shell, Saturn Oil & Gas - Crude oil up to USD 100 in May?

In recent weeks, even experienced investors have learned a lot about the oil market. When the price of WTI slipped into the red in April 2020, this was a first in the history of black gold. On the one hand, the oversupply of producers put pressure on prices, but speculators al...
Mario Hose | May 6, 2020 |

Let's talk about 'the great copper squeeze'

We continue to cover the copper story by looking at the supply and demand cycle, the EV movement, and the details behind the copper squeeze. World Copper Ltd. (TSXV:WCU) CEO Nolan Peterson, joins The Market Herald Canada’s Coreena Robertson on the Expert...
Coreena Robertson | August 14, 2023 |

Apple's (NASDAQ: AAPL) bet on Liquidmetal about to pay off?

Apple Inc. ( NASDAQ: AAPL , Stock Forum ) loves to think of lucrative new uses for other people's bright ideas. For instance, the original iPod wouldn't have been possible without Toshiba's innovative 1.8-inch hard drive. And when Steve Jobs learned about Gorilla Glass...
David Zeiler | October 28, 2012 |

A world energy crisis driving a renewed interest in uranium

Welcome to The Market Herald Canada’s Capital Compass. Many companies are considering a new path to clean energy in the fight against climate change. Our next company is publicly traded on the venture exchange and is utilizing uranium in this pursuit...
Brieanna McCutcheon | October 24, 2023 |

Gold Daily News: Friday, February 28

The gold futures contract lost 0.04% on Thursday, as it continued to fluctuate after retracing most of Friday’s-Monday’s rally. The daily trading range remained relatively big yesterday, as it reached over 25 dollars. It shows how high short-t...
Paul Rejczak | February 28, 2020 |

Gold Daily News: Monday, March 2

The gold futures contract lost 4.61% on Friday, as it retraced its whole February advance in just one day. The price collapsed below $1,600 mark despite the ongoing corona virus scare. The recent short-term volatility marked a topping pattern before that sell-off. Invest...
Paul Rejczak | March 2, 2020 |

Gold Daily News: Friday, March 13

The gold futures lost 3.17% on Thursday, as it fell below $1,600 level and reached the daily low of $1,560.40. Yellow metal fell the lowest since early February following financial markets liquidity squeeze. Earlier in the week the market bounced off Monday&CloseCurlyQuote...
Paul Rejczak | March 13, 2020 |
1 2 3 4 5 6